Contact this trialFirst, we need to learn more about you.
Non-small-cell lung cancer (NSCLC) for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1 & 2
New York, New York
This trial is testing a combined treatment of two drugs, dupilumab and cemiplimab, for early-stage lung cancer patients. Participants will receive the drugs before surgery and will be monitored
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.